Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
D000243:Adenosine Deaminase / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D002648:Child; D002675:Child, Preschool; D003070:Coformycin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000201:enzymology; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology; D008297:Male; D009700:Nucleoside Deaminases / Q000172:deficiency*; D015649:Pentostatin; D010430:Pentosyltransferases / Q000172:deficiency*; D011683:Purine-Nucleoside Phosphorylase / Q000172:deficiency*; D014155:Transcobalamins / Q000172:deficiency
D058892:Adenosine Deaminase Inhibitors; D014155:Transcobalamins; D003070:Coformycin; D015649:Pentostatin; D010430:Pentosyltransferases; D011683:Purine-Nucleoside Phosphorylase; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase